Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析

◆英語タイトル:Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH843FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kyowa Kirin Co Ltd (4151) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kyowa Kirin Co Ltd (Kyowa Kirin), a subsidiary of Kirin Holdings Co Ltd, is a research and development based biotechnology company. It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company operates through a network of subsidiaries in the US, Europe and Asia. Kyowa Kirin is headquartered in Tokyo, Japan.

Kyowa Kirin Co Ltd Key Recent Developments

Mar 25,2021: Twist Bioscience and Kyowa Kirin partner for GPCR antibody discovery
Feb 25,2021: Harvard University and Kyowa Kirin enter strategic research alliance
Feb 04,2021: Kyowa Kirin announces changes to its organization
Jan 02,2021: Axcelead and Kyowa Kirin started an innovative collaboration in small-molecule drug development
Oct 20,2020: Kyowa Kirin North America announces recipients of Patient Education grants to address disparities for African-American Patients with cutaneous T-Cell Lymphomas

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Kyowa Kirin Co Ltd – Key Facts
Kyowa Kirin Co Ltd – Key Employees
Kyowa Kirin Co Ltd – Key Employee Biographies
Kyowa Kirin Co Ltd – Major Products and Services
Kyowa Kirin Co Ltd – History
Kyowa Kirin Co Ltd – Company Statement
Kyowa Kirin Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Kyowa Kirin Co Ltd – Business Description
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
R&D Overview
Kyowa Kirin Co Ltd – Corporate Strategy
Kyowa Kirin Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Kyowa Kirin Co Ltd – Strengths
Kyowa Kirin Co Ltd – Weaknesses
Kyowa Kirin Co Ltd – Opportunities
Kyowa Kirin Co Ltd – Threats
Kyowa Kirin Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Kyowa Kirin Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 25, 2021: Twist Bioscience and Kyowa Kirin partner for GPCR antibody discovery
Feb 25, 2021: Harvard University and Kyowa Kirin enter strategic research alliance
Feb 04, 2021: Kyowa Kirin announces changes to its organization
Jan 02, 2021: Axcelead and Kyowa Kirin started an innovative collaboration in small-molecule drug development
Oct 20, 2020: Kyowa Kirin North America announces recipients of Patient Education grants to address disparities for African-American Patients with cutaneous T-Cell Lymphomas
Jul 13, 2020: Kyowa Kirin announces patient education grant program to address disparities for African American patients with cutaneous t-cell lymphomas (CTCL)
Jun 29, 2020: Kyowa Kirin names Finance Executive Ana Bastiani-Posner as Executive Vice President, Chief Financial Officer, North America
Feb 05, 2020: Kyowa Kirin announces its organization changes
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Kyowa Kirin Co Ltd, Key Facts
Kyowa Kirin Co Ltd, Key Employees
Kyowa Kirin Co Ltd, Key Employee Biographies
Kyowa Kirin Co Ltd, Major Products and Services
Kyowa Kirin Co Ltd, History
Kyowa Kirin Co Ltd, Other Locations
Kyowa Kirin Co Ltd, Subsidiaries
Kyowa Kirin Co Ltd, Joint Venture
Kyowa Kirin Co Ltd, Key Competitors
Kyowa Kirin Co Ltd, Ratios based on current share price
Kyowa Kirin Co Ltd, Annual Ratios
Kyowa Kirin Co Ltd, Annual Ratios (Cont...1)
Kyowa Kirin Co Ltd, Annual Ratios (Cont...2)
Kyowa Kirin Co Ltd, Interim Ratios
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Kyowa Kirin Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nissan Chemical Corp (4021):企業の財務・戦略的SWOT分析
    Nissan Chemical Corp (4021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cemex SAB de CV (CEMEXCPO):企業の財務・戦略的SWOT分析
    Cemex SAB de CV (CEMEXCPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • InDex Pharmaceuticals Holding AB (INDEX):企業の財務・戦略的SWOT分析
    Summary InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical company that offers treatments for immunological diseases. The company’s lead compound cobitolimod, currently in the phase 2 stage, is intended for the treatment of moderate to severe treatment active refractory ulc …
  • Proteus Digital Health Inc-医療機器分野:企業M&A・提携分析
    Summary Proteus Digital Health Inc (Proteus) is a medical device company which develops and sells digital medicine for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digita …
  • Tikcro Technologies Ltd (TIKRF):企業の財務・戦略的SWOT分析
    Summary Tikcro Technologies Ltd (Tikcro) is a biotechnology company that discovers, develops, manufactures and markets antibodies. The company undertakes clinical trials for its pipeline products PD1, PDL1, PDL2, TIGIT and CTLA-4 products, among others. Its products are based on 3D antigens designed …
  • BE Semiconductor Industries NV (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries NV (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Gokul Refoils & Solvent Ltd. (GOKUL):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Compugen Ltd.:企業のM&A・事業提携・投資動向
    Compugen Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Compugen Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Shell Oman Marketing Co (SOMS):企業の財務・戦略的SWOT分析
    Summary Shell Oman Marketing Co (Shell Oman), formerly Shell Marketing (Oman) Ltd, is an oil and gas company that markets fuel and lubricants. The company provides engine oils and grease for cars, motorcycles and trucks. It also markets Shell automotive, aviation and marine products. Shell Oman owns …
  • Nippon Steel & Sumikin Chemical Co Ltd:企業の戦略的SWOT分析
    Nippon Steel & Sumikin Chemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • NaturalNano Inc (NNAN):企業の財務・戦略的SWOT分析
    Summary NaturalNano Inc (NaturalNano) is a nanomaterial company that develops and offers proprietary technologies and processes to provide nanotubes. The company’s products include PleximerTM, a turnkey HNT polymer concentrate available in pellet form that can be added directly into a polymer extrud …
  • North China Pharmaceutical Group Corp-製薬・医療分野:企業M&A・提携分析
    Summary North China Pharmaceutical Group Corp (NCPC) is a healthcare products provider that manufactures and distributes antibiotic bulks and formulations, vitamins and nutrition products. The company’s products comprise antibiotics, penicillin, amoxicillin, streptomycin sulfate, cefradine, 7-ADCA, …
  • Meiji Yasuda Life Insurance Company:企業の戦略・SWOT・財務分析
    Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Ramsay Health Care Ltd (RHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Ramsay Health Care Ltd (RHC) is a global healthcare group that owns and operates through healthcare facilities. Its facilities cater for a range of health care needs from day surgery procedures to complex surgeries. The company also provides psychiatric care and rehabilitation services. RHC …
  • Essar Power Limited:発電所・企業SWOT分析
    Essar Power Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Transat A.T. Inc:企業の戦略・SWOT・財務情報
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cyclo Therapeutics Inc (CTDH):企業の財務・戦略的SWOT分析
    Summary Cyclo Therapeutics Inc (Cyclo Therapeutics), formerly CTD Holdings Inc, is a biotechnology company that develops and manufactures cyclodextrin-based drugs. It is investigating Trappsol Cyclo, an orphan drug against Niemann-Pick disease type C and Alzheimer’s disease. The company also develop …
  • Rollprint Packaging Products Inc.:企業の戦略・SWOT・財務情報
    Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Compania Espanola de Petroleos SAU:石油・ガス:M&Aディール及び事業提携情報
    Summary Compania Espanola de Petroleos SAU (CEPSA) is an integrated energy company. It explores for, produces, refines, transports, and markets and sells crude oil, petroleum products, and natural gas. The company also generates and sells electricity and thermal power to industrial customers and con …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆